D-1350-2015 Class III Terminated

Recalled by Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals — Huntsville, AL

FDA drug recall D-1350-2015 was initiated by Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals on Aug 13, 2015 and is designated Class III. Reason for recall: Labeling: Incorrect Or Missing Package Insert: Product is labeled with unapproved labeling. The recall status is terminated (terminated Aug 21, 2015). Affected quantity: 360 Bottles.

Recall details

Product Type
Drugs
Report Date
Aug 26, 2015
Initiation Date
Aug 13, 2015
Termination Date
Aug 21, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
360 Bottles

Product description

AMPICILLIN CAPSULES, USP, 250 mg, 500 count bottles, Rx only, Manufactured for: DAVA Pharmaceuticals, Inc., Fort Lee, NJ, By: Suir Pharma Ireland Ltd., Clonmel, Ireland, NDC: 67253-180-50

Reason for recall

Labeling: Incorrect Or Missing Package Insert: Product is labeled with unapproved labeling.

Distribution pattern

U.S. Including: OH

Code information

Lot #: 52217, Expiry: 04/18

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1350-2015
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1350-2015. Report a data issue: hello@regdatalab.com.